Cell Therapy for Macular Degeneration—first Phase I/Ii Pluripotent Stem Cell-Based Clinical Trial Shows Promise

Science China Life Sciences - China
doi 10.1007/s11427-014-4791-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Treatment of Age-Related Macular Degeneration With Pluripotent Stem Cell-Derived Retinal Pigment Epithelium

Current Eye Research
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2019English

Progress of Stem/Progenitor Cell-Based Therapy for Retinal Degeneration

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

“Footprint-Free” Human Induced Pluripotent Stem Cell-Derived Astrocytes for in Vivo Cell-Based Therapy

Stem Cells and Development
Developmental BiologyHematologyCell Biology
2014English

Can Pluripotent Stem Cells Be Used in Cell-Based Therapy?

Cellular Reprogramming
BiotechnologyDevelopmental BiologyCell Biology
2014English

Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson’s Disease

Scientific Reports
Multidisciplinary
2016English

A Strategy Using Pluripotent Stem Cell-Derived Hepatocytes for Stem Cell-Based Therapies

2011English

Phase 1 Clinical Study of an Embryonic Stem Cell–derived Retinal Pigment Epithelium Patch in Age-Related Macular Degeneration

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2018English

A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy

Stem Cell Reports
BiochemistryGeneticsDevelopmental BiologyCell Biology
2015English

Cell Therapy for Parkinson’s Disease With Induced Pluripotent Stem Cells

Clinical Neurology
Neurology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy